H.C. Wainwright lowered the firm’s price target on Rockwell Medical (RMTI) to $2 from $2.50 and keeps a Buy rating on the shares. The firm cites the company’s “more modest” sales ramp for the target cut.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RMTI:
- Rockwell Medical Earnings Call Balances Progress and Risk
- Rockwell Medical price target lowered to $4 from $5 at Maxim
- Rockwell Medical’s Cost Cuts Raise Execution Risk and Threaten Future Growth Prospects
- Rockwell Med Updates Corporate Presentation for Investors
- Options Volatility and Implied Earnings Moves Today, March 26, 2026